Trial · NCT07906392
ESP Versus SPSIP Block for Pain Relief After Shoulder Arthroscopy
NCT07906392, Not applicable, Not yet recruiting, Ferit Yetik
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. ESP Versus SPSIP Block for Pain Relief After Shoulder Arthroscopy. Trials, record NCT07906392. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07906392
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- ESP Versus SPSIP Block for Pain Relief After Shoulder Arthroscopy
- NCT number
- NCT07906392
- Status
- Not yet recruiting
- Phases
- Not applicable
- Enrollment
- 80 participants, estimated
- Lead sponsor
- Ferit Yetik
- Conditions
- Postoperative Pain
- Interventions
- High Thoracic Erector Spinae Plane Block, Serratus Posterior Superior Intercostal Plane Block
- First posted
- 2026-10-30
- Last updated
- 2026-11-02
Source ClinicalTrials.gov
Registered outcomes6
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Total PCA Tramadol Consumption During the First 24 Hours After Surgery | First 24 hours after surgery | The cumulative dose of tramadol delivered through the intravenous patient-controlled analgesia (PCA) pump during the first 24 postoperative hours will be recorded in milligrams and compared between the groups. Only tramadol actually delivered by the PCA pump will be included. Intraoperative tramadol and rescue meperidine will not be included in this outcome. |
| Secondary | Postoperative Pain at Rest | At 0, 2, 4, 8, 16, and 24 hours after surgery | Pain intensity at rest will be assessed using an 11-point Numerical Rating Scale (NRS), ranging from 0 (no pain) to 10 (worst imaginable pain). Scores will be compared between the groups at each assessment time point. |
| Secondary | Postoperative Pain During Movement | At 0, 2, 4, 8, 16, and 24 hours after surgery | Pain intensity during movement will be assessed using an 11-point Numerical Rating Scale (NRS), ranging from 0 (no pain) to 10 (worst imaginable pain). Scores will be compared between the groups at each assessment time point. |
| Secondary | Quality of Recovery-15 (QoR-15) Score | At 24 hours after surgery | Postoperative quality of recovery will be assessed using the 15-item Quality of Recovery-15 (QoR-15) questionnaire. The total score ranges from 0 to 150, with higher scores indicating better recovery. Total scores will be compared between the groups. |
| Secondary | Incidence of Block-Related Complications | From block administration through 24 hours after surgery | The number and percentage of participants experiencing complications related to the regional block will be recorded and compared between the groups. The type of each complication will be documented. |
| Secondary | Incidence of Opioid-Related Adverse Effects | First 24 hours after surgery | The number and percentage of participants experiencing opioid-related adverse effects, including nausea, vomiting, and pruritus, will be recorded and compared between the groups. Each adverse effect will be documented separately. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07906392
GET https://conductscience.org/api/trials/v1/NCT07906392/registered